182 related articles for article (PubMed ID: 37239440)
21. Netherton syndrome with extensive skin peeling and failure to thrive due to a homozygous frameshift mutation in SPINK5.
Geyer AS; Ratajczak P; Pol-Rodriguez M; Millar WS; Garzon M; Richard G
Dermatology; 2005; 210(4):308-14. PubMed ID: 15942217
[TBL] [Abstract][Full Text] [Related]
22. A compound heterozygous mutation of the SPINK5 gene in a Taiwanese boy with Netherton syndrome.
Chao SC; Tsai YM; Lee JY
J Formos Med Assoc; 2003 Jun; 102(6):418-23. PubMed ID: 12923596
[TBL] [Abstract][Full Text] [Related]
23. Netherton syndrome: mutation analysis of two Taiwanese families.
Lin SP; Huang SY; Tu ME; Wu YH; Lin CY; Lin HY; Lee-Chen GJ
Arch Dermatol Res; 2007 Jun; 299(3):145-50. PubMed ID: 17415575
[TBL] [Abstract][Full Text] [Related]
24. New compound heterozygous SPINK5 mutations in a Chinese infant with Netherton syndrome.
Wang Q; Qiu F; Wu H; Fan YM
J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e782-e784. PubMed ID: 34138484
[No Abstract] [Full Text] [Related]
25. LEKTI demonstrable by immunohistochemistry of the skin: a potential diagnostic skin test for Netherton syndrome.
Ong C; O'Toole EA; Ghali L; Malone M; Smith VV; Callard R; Harper JI
Br J Dermatol; 2004 Dec; 151(6):1253-7. PubMed ID: 15606522
[TBL] [Abstract][Full Text] [Related]
26. Netherton syndrome previously misdiagnosed as hyper IgE syndrome caused by a probable mutation in SPINK5 C.
Özyurt K; Atasoy M; Ertaş R; Ulaş Y; Akkuş MR; Kiraz A; Hennies HC
Turk J Pediatr; 2019; 61(4):604-607. PubMed ID: 31990481
[TBL] [Abstract][Full Text] [Related]
27. Molecular analysis of a series of Israeli families with Comèl-Netherton syndrome.
Israeli S; Sarig O; Garty BZ; Indelman M; Bergman R; Sprecher E; Goldberg I
Dermatology; 2014; 228(2):183-8. PubMed ID: 24577329
[TBL] [Abstract][Full Text] [Related]
28. Genetic analysis of a severe case of Netherton syndrome and application for prenatal testing.
Müller FB; Hausser I; Berg D; Casper C; Maiwald R; Jung A; Jung H; Korge BP
Br J Dermatol; 2002 Mar; 146(3):495-9. PubMed ID: 11952552
[TBL] [Abstract][Full Text] [Related]
29. Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population.
Kato A; Fukai K; Oiso N; Hosomi N; Murakami T; Ishii M
Br J Dermatol; 2003 Apr; 148(4):665-9. PubMed ID: 12752122
[TBL] [Abstract][Full Text] [Related]
30. Netherton Syndrome: A Genotype-Phenotype Review.
Sarri CA; Roussaki-Schulze A; Vasilopoulos Y; Zafiriou E; Patsatsi A; Stamatis C; Gidarokosta P; Sotiriadis D; Sarafidou T; Mamuris Z
Mol Diagn Ther; 2017 Apr; 21(2):137-152. PubMed ID: 27905021
[TBL] [Abstract][Full Text] [Related]
31. A novel SPINK5 mutation and successful subcutaneous immunoglobulin replacement therapy in a child with Netherton syndrome.
Zelieskova M; Banovcin P; Kozar M; Kozarova A; Nudzajova Z; Jesenak M
Pediatr Dermatol; 2020 Nov; 37(6):1202-1204. PubMed ID: 32767583
[TBL] [Abstract][Full Text] [Related]
32. [Netherton syndrome].
Serra-Guillén C; Torrelo A; Drake M; Armesto S; Fernández-Llaca H; Zambrano A
Actas Dermosifiliogr; 2006 Jun; 97(5):348-50. PubMed ID: 16956571
[TBL] [Abstract][Full Text] [Related]
33. Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients.
Komatsu N; Saijoh K; Jayakumar A; Clayman GL; Tohyama M; Suga Y; Mizuno Y; Tsukamoto K; Taniuchi K; Takehara K; Diamandis EP
J Invest Dermatol; 2008 May; 128(5):1148-59. PubMed ID: 17989726
[TBL] [Abstract][Full Text] [Related]
34. Netherton syndrome: a case report and review of the literature.
Sun JD; Linden KG
Int J Dermatol; 2006 Jun; 45(6):693-7. PubMed ID: 16796630
[TBL] [Abstract][Full Text] [Related]
35. Cathelicidin represents a new target for manipulation of skin inflammation in Netherton syndrome.
Zingkou E; Pampalakis G; Sotiropoulou G
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165831. PubMed ID: 32442469
[TBL] [Abstract][Full Text] [Related]
36. Establishment of an induced pluripotent stem cell line (SAHGMUi001-A) from a patient with Netherton syndrome carrying SPINK5 mutation.
Xu M; Wang L; Yin J; Xiong J; Guo Q; Yang W
Stem Cell Res; 2021 Mar; 51():102213. PubMed ID: 33556917
[TBL] [Abstract][Full Text] [Related]
37. SPINK5 and Netherton syndrome: novel mutations, demonstration of missing LEKTI, and differential expression of transglutaminases.
Raghunath M; Tontsidou L; Oji V; Aufenvenne K; Schürmeyer-Horst F; Jayakumar A; Ständer H; Smolle J; Clayman GL; Traupe H
J Invest Dermatol; 2004 Sep; 123(3):474-83. PubMed ID: 15304086
[TBL] [Abstract][Full Text] [Related]
38. Netherton syndrome with ichthyosis linearis circumflexa and trichorrhexis invaginatum.
Ng E; Hale CS; Meehan SA; Cohen DE
Dermatol Online J; 2014 Dec; 20(12):. PubMed ID: 25526335
[TBL] [Abstract][Full Text] [Related]
39. SPINK5 is associated with early-onset and CHI3L1 with late-onset atopic dermatitis.
Dežman K; Korošec P; Rupnik H; Rijavec M
Int J Immunogenet; 2017 Oct; 44(5):212-218. PubMed ID: 28681574
[TBL] [Abstract][Full Text] [Related]
40. Generation and Clinical Application of Gene-Modified Autologous Epidermal Sheets in Netherton Syndrome: Lessons Learned from a Phase 1 Trial.
Di WL; Lwin SM; Petrova A; Bernadis C; Syed F; Farzaneh F; Moulding D; Martinez AE; Sebire NJ; Rampling D; Virasami A; Zamiri M; Wang W; Hara H; Kadiyirire T; Abdul-Wahab A; Martinez-Queipo M; Harper JI; McGrath JA; Thrasher AJ; Mellerio JE; Qasim W
Hum Gene Ther; 2019 Sep; 30(9):1067-1078. PubMed ID: 31288584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]